DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Dr. Lal Path Labs Ltd. — Outcome of Board Meeting

NSE 58 min ago·24 Jul 2026, 8:07 am

DR. LAL Path Labs

Dr. Lal Path Labs has announced that it has submitted its financial results for the period ending June 30, 2026, to the stock exchange. This submission marks a key corporate governance milestone, as it signals that the company has completed its internal review and audit processes for the quarter.

For investors, this update is significant as it provides the first official data point for the company's performance in the new financial year. It allows the market to gauge the company's operational health and financial trajectory following the previous reporting period.

Investors should watch for the official filing and subsequent press release to see if the results meet or exceed market expectations. This will be the primary trigger for any immediate price movement in the stock.